Hikma Pharmaceutical reported $1.38B in Current Liabilities for its fiscal semester ending in June of 2024.

Current Liabilities Change Date
Almirall EUR 274.01M 14.41M Jun/2024
AstraZeneca USD 25.93B 2.64B Sep/2024
Autolus Therapeutics Ltd 52.47M 11.57M Sep/2024
Bayer EUR 25.05B 6.51B Sep/2024
Fresenius EUR 8.28B 968M Sep/2024
Galapagos EUR 351.23M 13.55M Sep/2024
Genmab DKK 4.58B 221M Sep/2024
GlaxoSmithKline GBP 21.46B 1.11B Sep/2024
GRIFOLS EUR 4.11B 1.8B Jun/2024
Hikma Pharmaceutical USD 1.38B 41M Jun/2024
Lonza CHF 2.61B 154M Jun/2024
Merck EUR 9.93B 8M Jun/2024
Orion EUR 403.8M 54.4M Sep/2024
Recordati EUR 887.22M 85.95M Jun/2024
Roche Holding CHF 26.6B 1.78B Jun/2024
Sanofi 30.03B 5.82B Jun/2024
UCB EUR 2.8B 182M Jun/2024